Lemaitre Dan
SEC CIK 1478479 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GMED | GLOBUS MEDICAL INC | Dir | 1,097 | — | $7.79M | 8 | 2023-01-27 | 2024-11-21 |
Most active insiders at GMED, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ZARRILLI STEPHEN T | Dir | — | $4.28M |
| 2 | Davidar David D | Dir | — | $4.17M |
| 3 | Huller Kelly | SVP, GC, Corp. Sec | — | $3.44M |
| 4 | TOBIN JAMES R | Dir | — | $2.24M |
| 5 | Kline Kyle | SVP, CFO | — | $2.03M |
| 6 | RHOADS ANN D | Dir | — | $818.0K |
| 7 | Norwalk Leslie V | Dir | — | $557.6K |
| 8 | Paul David C | Executive COB, Dir, 10% | — | — |
Lemaitre Dan made no open-market trades at GMED in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-25 | 2024-11-21+ | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | M - OptEx | $65.05 | +14.4K | 1,097 | New | +$935.1K |
| DM | 2024-11-25 | 2024-11-21+ | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | S - Sale+OE | $85.00 | -14.4K | 0 | -100% | -$1.22M |
| DM | 2024-05-14 | 2024-05-10 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | M - OptEx | $46.87 | +52.5K | 63.3K | +486% | +$2.46M |
| D | 2024-05-14 | 2024-05-10 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | S - Sale+OE | $64.61 | -63.3K | 0 | -100% | -$4.09M |
| DM | 2023-05-17 | 2023-05-15 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | M - OptEx | $25.43 | +43.5K | 12.2K | New | +$1.10M |
| D | 2023-05-17 | 2023-05-15 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | S - Sale+OE | $56.98 | -43.5K | 10.8K | -80% | -$2.48M |
| D | 2023-02-13 | 2023-02-09 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | M - OptEx | $23.95 | +5,550 | 10.8K | +106% | +$132.9K |
| D | 2023-01-30 | 2023-01-27 | GMED | GLOBUS MEDICAL INC | Lemaitre Dan | Dir | M - OptEx | $12.59 | +5,250 | 5,250 | New | +$66.1K |
Purchase Sale Sale after option exercise All abbreviations